Suppr超能文献

叶黄素在整个生命历程中对心脏代谢健康的影响:一项系统评价和荟萃分析。

The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis.

作者信息

Leermakers Elisabeth Tm, Darweesh Sirwan Kl, Baena Cristina P, Moreira Eduardo M, Melo van Lent Debora, Tielemans Myrte J, Muka Taulant, Vitezova Anna, Chowdhury Rajiv, Bramer Wichor M, Kiefte-de Jong Jessica C, Felix Janine F, Franco Oscar H

机构信息

Department of Epidemiology and

Department of Epidemiology and.

出版信息

Am J Clin Nutr. 2016 Feb;103(2):481-94. doi: 10.3945/ajcn.115.120931. Epub 2016 Jan 13.

Abstract

BACKGROUND

The antioxidant lutein is suggested as being beneficial to cardiometabolic health because of its protective effect against oxidative stress, but evidence has not systematically been evaluated.

OBJECTIVE

We aimed to evaluate systematically the effects of lutein (intake or concentrations) on cardiometabolic outcomes in different life stages.

DESIGN

This is a systematic review with meta-analysis of literature published in MEDLINE, Embase, Cochrane Central, Web of Science, PubMed, and Google Scholar up to August 2014. Included were trials and cohort, case-control, and cross-sectional studies in which the association between lutein concentrations, dietary intake, or supplements and cardiometabolic outcomes was reported. Two independent investigators reviewed the articles.

RESULTS

Seventy-one relevant articles were identified that included a total of 387,569 participants. Only 1 article investigated the effects of lutein during pregnancy, and 3 studied lutein in children. Furthermore, 31 longitudinal, 33 cross-sectional, and 3 intervention studies were conducted in adults. Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake. There was no significant association with type 2 diabetes mellitus (pooled RR: 0.97; 95% CI: 0.77, 1.22), but higher lutein was associated with a lower risk of metabolic syndrome (pooled RR: 0.75; 95% CI: 0.60, 0.92) for the highest compared with the lowest tertile. The literature on risk factors for cardiometabolic diseases showed that lutein might be beneficial for atherosclerosis and inflammatory markers, but there were inconsistent associations with blood pressure, adiposity, insulin resistance, and blood lipids.

CONCLUSIONS

Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health. However, evidence mainly comes from observational studies in adults, whereas large-scale intervention studies and studies of lutein during pregnancy and childhood are scarce.

摘要

背景

抗氧化剂叶黄素因其对氧化应激的保护作用而被认为有益于心脏代谢健康,但相关证据尚未得到系统评估。

目的

我们旨在系统评估叶黄素(摄入量或浓度)在不同生命阶段对心脏代谢结局的影响。

设计

这是一项系统综述,并对截至2014年8月发表在MEDLINE、Embase、Cochrane Central、Web of Science、PubMed和谷歌学术上的文献进行荟萃分析。纳入的研究包括试验、队列研究、病例对照研究和横断面研究,这些研究报告了叶黄素浓度、饮食摄入量或补充剂与心脏代谢结局之间的关联。两名独立研究人员对文章进行了审查。

结果

共识别出71篇相关文章,涉及387,569名参与者。仅有1篇文章研究了孕期叶黄素的作用,3篇研究了儿童期的叶黄素。此外,针对成年人开展了31项纵向研究、33项横断面研究和3项干预研究。荟萃分析表明,与最低三分位数相比,叶黄素血液浓度或摄入量最高三分位数者患冠心病(合并相对危险度:0.88;95%置信区间:0.80, 0.98)和中风(合并相对危险度:0.82;95%置信区间:0.72, 0.93)的风险较低。与2型糖尿病无显著关联(合并相对危险度:0.97;95%置信区间:0.77, 1.22),但与最低三分位数相比,最高三分位数的较高叶黄素水平与较低的代谢综合征风险相关(合并相对危险度:0.75;95%置信区间:0.60, 0.92)。关于心脏代谢疾病危险因素的文献表明,叶黄素可能对动脉粥样硬化和炎症标志物有益,但与血压、肥胖、胰岛素抵抗和血脂的关联并不一致。

结论

我们的研究结果表明,较高的饮食摄入量和较高的血液叶黄素浓度通常与更好的心脏代谢健康相关。然而,证据主要来自成年人的观察性研究,而大规模干预研究以及孕期和儿童期叶黄素的研究较少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验